Hoshizuka Keiaien Sanatorium
Corporate brand
UnclaimedHoshizuka Keiaien Sanatorium is a Japanese national sanatorium in Kanoya, Kagoshima, serving people affected by Hansen's disease, including former patients.
Last updated August 26, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Hoshizuka Keiaien Sanatorium, also known as National Sanatorium Hoshizuka Keiaien, is a government sanatorium in Kanoya, Kagoshima Prefecture, Japan. It was established in 1935 as part of the Japanese state's expansion of institutional facilities for people with Hansen's disease, historically called leprosy. The institution was the fourth national sanatorium established under that expansion program, following the creation of earlier prefectural and national facilities. Its opening ceremony took place on October 28, 1935, with Fumio Hayashi serving as its first director. The sanatorium's history reflects the medical, administrative, and social consequences of Japan's long-running segregation policy. During the early decades of its operation, residents were not simply receiving medical treatment; many were confined for extended periods under laws and practices that separated people with Hansen's disease from wider society. The institution also became associated with measures intended to prevent patients from having children, including vasectomies and pregnancy terminations. Historical records cited in connection with Hoshizuka Keiaien identify 334 vasectomies between 1936 and 1971 and 45 interrupted pregnancies between 1950 and 1959. These practices formed part of a broader discriminatory system rather than a modern healthcare model. Hoshizuka Keiaien was also a site of important therapeutic developments. At a meeting of the Japanese Leprosy Association held at the sanatorium on November 2 and 3, 1947, the effects of the sulfone drug promin were reported. Promin treatment began at the institution in November 1948, and its results were described as striking in comparison with earlier disappointing trials of cepharanthin. The success of promin contributed to a patient-led demand for access to the treatment. The first patient at the sanatorium reported as having been cleared with promin was discharged in April 1953, an event remembered in institutional and Japanese Hansen's disease history. The facility was affected by wartime air raids in 1945. Attacks on March 18, June 8, and August 12 caused the deaths of six patients in total. Earlier records also document severe scabies outbreaks among residents, with recorded cases rising from 83 in 1935 to thousands by the late 1930s and more than 12,000 in 1946, although the figures are historical counts and not measures of current activity. Japan's legal framework began to change in the 1990s. The Leprosy Prevention Law of 1953 was abolished in April 1996, ending the statutory foundation of the former segregation system. A compensation lawsuit began in July 1998, and on May 11, 2001, the court found the former policy unconstitutional. The judgment was confirmed on May 25, 2001, with compensation awards reported at between 8 million and 14 million yen depending on the duration of the unconstitutional restrictions. Hoshizuka Keiaien therefore represents both a continuing care institution and an important historical site in the story of medical discrimination, patient rights, and the transition away from compulsory isolation in Japan.
History
Hoshizuka Keiaien was established in 1935 in Kanoya, Kagoshima, as Japan's fourth national sanatorium. Its creation followed the government's decision to enlarge the country's network of facilities for people with Hansen's disease after earlier prefectural and national institutions had been established. Local resistance to the facility was reportedly limited compared with opposition encountered in some other areas. The opening ceremony took place on October 28, 1935, and Fumio Hayashi became the first director. Einosuke Shionuma was appointed the second director in February 1944. The early institution operated within Japan's segregation-based Hansen's disease system. Residents were generally treated as people who needed to be separated from society for long periods, even as medical understanding and treatment changed. Historical material concerning the sanatorium records extensive scabies outbreaks, with documented cases increasing sharply during the late 1930s and reaching more than 12,000 in 1946. The facility also experienced wartime destruction and loss of life: air raids on March 18, June 8, and August 12, 1945, killed six patients. Hoshizuka Keiaien became connected with the introduction of modern sulfone therapy. At a Japanese Leprosy Association congress held at the sanatorium on November 2 and 3, 1947, the effects of promin were reported. The drug had initially received limited attention because cepharanthin, another treatment tested earlier, had produced disappointing results. Promin treatment commenced at Hoshizuka Keiaien in November 1948 and was described as producing remarkable effects. Patients subsequently organized or participated in a demand movement for access to the medicine. The first patient at the institution reported as cleared with promin was discharged in April 1953. The institution's history also includes coercive reproductive practices. Vasectomy had been introduced in the broader Hansen's disease system before Hoshizuka Keiaien's establishment, and the practice was justified publicly through claims concerning pregnancy, childbirth, and the health of women with Hansen's disease. Historical accounts identify the underlying purpose as the prevention of reproduction among patients and the attempted eradication of the patient population. At Hoshizuka Keiaien, 334 vasectomies were recorded between 1936 and 1971, while 45 interrupted pregnancies were recorded from 1950 to 1959. These facts are central to understanding the facility's legacy and the human-rights abuses associated with Japan's former policy. The legal order supporting compulsory isolation began to change late in the twentieth century. Japan abolished the 1953 Leprosy Prevention Law in April 1996. Litigation seeking redress began in July 1998. On May 11, 2001, the court held the former prevention policy unconstitutional, and the ruling was confirmed on May 25. Compensation reportedly ranged from 8 million to 14 million yen according to the period during which a claimant had been subject to the unconstitutional restrictions. The sanatorium is therefore both a healthcare institution and a historical repository of Japan's Hansen's disease policy. Its significance extends beyond clinical treatment: it reflects the shift from compulsory segregation toward rights-based recognition, compensation, and support for former patients. Publicly available reference material does not provide a complete current service profile, patient census, leadership roster, or detailed institutional chronology, so those aspects should not be inferred from the historical record alone.
- 2001
Compensation judgment confirmed
[1]A court ruling that the former prevention policy was unconstitutional was confirmed, with compensation awarded according to the duration of restrictions.
- 1996
Leprosy Prevention Law abolished
[1]Japan abolished the 1953 law that had provided the legal framework for the former segregation policy.
- 1953
First promin-cleared patient discharged
[1]The first patient at the sanatorium reported as cleared through promin was discharged in April.
- 1948
Promin treatment begins
[1]Promin treatment started in November, producing results that were described as highly significant and leading to strong patient demand.
- 1947
Promin effects reported
[1]Reports on the effects of promin were presented at a Japanese Leprosy Association congress held at the sanatorium.
- 1945
Wartime air raids
[1]Three recorded air raids caused six patient deaths.
- 1944
Second director appointed
[1]Einosuke Shionuma became the institution's second director in February.
- 1935
Institution established
[1]Hoshizuka Keiaien was established as Japan's fourth national sanatorium for people with Hansen's disease.
- 1935
Opening ceremony held
[1]The official opening ceremony took place on October 28, with Fumio Hayashi as the first director.
Products and positioning
A Japanese national institution combining specialized care for people affected by Hansen's disease with a significant historical role in the country's treatment, segregation, and post-segregation legacy.
Healthcare and residential care · 1935
Hansen's disease sanatorium care
The institution's core function is specialized care for people affected by Hansen's disease, including long-term residents and former patients. The historical record places this service within Japan's national sanatorium system, whose role changed as treatment improved and compulsory segregation was dismantled.
Historical medical treatment · 1948
Promin treatment
Promin was a sulfone drug used at Hoshizuka Keiaien beginning in November 1948. Its reported effectiveness marked an important therapeutic development at the sanatorium and contributed to patient demands for access to the treatment. It is documented here as part of the institution's medical history, not as a current product offering.
Controversies
2001
Unconstitutionality of Japan's former segregation policy
Litigation brought by former Hansen's disease patients led to a 2001 ruling that the former Leprosy Prevention policy was unconstitutional. The case exposed the human-rights consequences of compulsory isolation and was followed by compensation awards.
Brand decisions
1996
End of the statutory segregation frameworkOtherBackground
The 1953 Leprosy Prevention Law had supported Japan's long-running isolation policy for people with Hansen's disease.
Action taken
Japan abolished the law in April 1996.
Aftermath
The abolition was followed by compensation litigation and the 2001 finding that the former policy was unconstitutional.
1948
Introduction of promin treatmentProduct launchBackground
Reports presented at the sanatorium in 1947 described promin's effects, while an earlier drug trial had disappointed patients and clinicians.
Action taken
Promin treatment began at Hoshizuka Keiaien in November 1948.
Aftermath
The treatment was reported to have striking effects and encouraged a patient movement demanding access. The first patient described as cleared with promin was discharged in 1953.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/hoshizuka-keiaien-sanatorium · Editorial policy · How profiles are compiled